TrialHuman vaccines & immunotherapeutics2024

Results of a phase I/IIa trial of SV-BR-1-GM inoculation with low-dose cyclophosphamide and interferon alpha (Bria-IMT) in metastatic breast cancer.

Charles L Wiseman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.